Stryker has signed a definitive merger agreement to acquire all outstanding shares of K2M Group, valued at $1.4bn.
K2M will operate as a wholly owned subsidiary of Stryker and as part of the company’s spine business following the completion of the transaction.
Go deeper with GlobalData
The transaction is expected to be closed in the last quarter of 2018, subject to customary closing conditions.
Based in the US, Stryker is a medical technology company that provides orthopaedic implants, while KTM, also based in the US, is a developer of complex and minimally invasive spine technologies.
The transaction will enable Stryker to expand its footprint in the spine and neurotechnology market and strengthen its manufacturing capabilities.
Syneron Candela has completed the acquisition of Denmark-based medical device company Ellipse for an undisclosed sum.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataBased in the US, Syneron Candela specialises in the development and manufacture of aesthetic medical products, while Ellipse is a manufacturer of high-quality laser and Intense Pulsed Light (IPL)-based systems for skin treatments.
The transaction enables Syneron Candela to expand its expertise in the multi-application space and enable it to provide its customers with a broad range of aesthetics products.
Royal Philips has completed the acquisition of Xhale Assurance for an undisclosed sum.
Xhale Assurance has developed a disposable pulse oximetry sensor, which can be placed on the wing of the nose to monitor a patient’s heart rate and blood oxygenation under low-perfusion conditions.
The acquisition of Xhale’s oximetry sensor is expected to enhance Royal Philips’ portfolio of oxygen saturation monitoring solutions and enable the company to offer patient monitoring technologies.
Based in the Netherlands, Royal Philips is a medical device company, while US-based Xhale Assurance is a developer of patient-centric monitoring solutions and sensor technologies.
